FeaturesSignalPricingFounders
AP

Action Potential Venture Capital

Venture CapitalActive

Action Potential Venture Capital is a strategic venture capital fund that invests in bioelectronic medicine and technology companies.

Cambridge, United StatesFounded 2017
11
Investments
0
Exits
—
AUM
0.0%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Action Potential Venture Capital.

Get started free

Investment Thesis & Strategy

Action Potential Venture Capital invests in bioelectronic medicine and technology companies across various stages, seeking to support innovative solutions in the healthcare sector.

Investment Activity

Deals per year over the last 4 years

1
2020
4
2021
2
2022
3
2023

Portfolio Companies

Selected investments from their portfolio of 11 companies

S
Soterius
Biotech · Series A, 2023
Active
C
Cortec
Biotech · Series A, 2023
Active
E
Enspire DBS
Biotech · Series A, 2023
Active
N
Neuromod Devices
Biotech · Growth, 2022
Active
S
Saluda Medical
Biotech · Growth, 2022
Active
B
Bioelectronic Technologies
Biotech · Seed, 2021
Active
H
Humm
Biotech · Series A, 2021
Active
L
Limula Medical
Biotech · Series A, 2021
Active
N
Nalu Medical
Biotech · Growth, 2021
Active
E
ElectroCore
Biotech · Growth, 2020
Active

Frequently Asked Questions

Action Potential Venture Capital focuses on Series A, Series B, Series C+ stage investments.

Related Investors

General Catalyst

Cambridge, United States · 737 deals

Atlas Venture

Cambridge, United States · 514 deals

F-Prime Capital

Cambridge, United States · 228 deals

MPM Capital

Cambridge, United States · 223 deals

Accomplice

Cambridge, United States · 222 deals

Flagship Pioneering

Cambridge, United States · 213 deals